These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28966496)

  • 1. Spectrum of meningioma with special reference to prognostic utility of ER,PR and Ki67 expression.
    Mukhopadhyay M; Das C; Kumari M; Sen A; Mukhopadhyay B; Mukhopadhyay B
    J Lab Physicians; 2017; 9(4):308-313. PubMed ID: 28966496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
    Hsu DW; Efird JT; Hedley-Whyte ET
    J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
    Shayanfar N; Mashayekh M; Mohammadpour M
    Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningioma Prognostic Tool Based on Correlation of Histopathological Grading and Immunohistochemistry.
    Shafat M; Khursheed N; Walvir N; Makhdoomi R; Ayesha Z
    Oman Med J; 2024 Mar; 39(2):e608. PubMed ID: 39055905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
    Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
    J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas.
    Fakhrjou A; Meshkini A; Shadrvan S
    Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in anterior skull base meningiomas.
    Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67.
    Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Prasad BC; Reddy MK
    J Clin Diagn Res; 2016 Jan; 10(1):EC15-9. PubMed ID: 26894073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
    Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
    Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.
    Naik PS; Deshmukh S; Khandeparkar SG; Joshi A; Babanagare S; Potdar J; Risbud NS
    J Midlife Health; 2015; 6(4):178-83. PubMed ID: 26903759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A; Céspedes G; Trejo E
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas.
    Khalid H
    Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma.
    Miyagishima DF; Sundaresan V; Gutierrez AG; Barak T; Yeung J; Moliterno J; McGuone D; Claus EB; Günel M
    J Neurosurg; 2023 Dec; 139(6):1638-1647. PubMed ID: 37243565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone receptors in benign intracranial meningiomas.
    Milenković S; Berisavac J; Cvetković-Dozić D; Skender-Gazibara M; Bojović V; Berisavac I
    J BUON; 2004; 9(3):295-8. PubMed ID: 17415829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
    Takei H; Buckleair LW; Powell SZ
    Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningiomas: correlation of Ki67 with histological grade.
    Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
    Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
    Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
    Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.